1) Ocular myasthenia gravis
眼肌型重症肌无力
1.
Thymectomy in treatment of ocular myasthenia gravis: A report of 17 cases;
胸腺切除术治疗眼肌型重症肌无力(附17例分析)
2.
Objective To study and estimate the value of SFEMG of the frontalis muscle in the diagnosis of ocular myasthenia gravis(OMG),comparing the sensitivity of the SFEMG of the frontalis muscle,repetitive nerve stimulation(RNS),blood concentration of antibody to the acetylcholine receptor(AchR-Ab) and neostigmine test.
目的分析眼肌型重症肌无力(OMG)患者额肌单纤维肌电图(SFEMG)表现并辅助临床诊断。
3.
Objective To evaluate single fiber electromyography (SFEMG) in the diagnosis of ocular myasthenia gravis (OMG).
目的 研究眼肌型重症肌无力 ( OMG)患者的单纤维肌电图 ( SFEMG)及与其他辅助检查的关系 ,期望对临床诊断提供帮助。
2) oEAMG
实验性自身免疫性眼肌型重症肌无力
1.
Objective: To establish a novel model of ocular experimental autoimmune myasthenia gravis (oEAMG) in HLA-DQ8 transgenic mice and study the immunologic pathogenesis of oEAMG .
目的： 利用HLA—DQ8转基因小鼠建立实验性自身免疫性眼肌型重症肌无力(oEAMG)模型，并探讨oEAMG免疫学发病机制。
3) Bulbar myasthenia gravis
球型重症肌无力
4) Myasthenia gravis
重症肌无力
1.
Preliminary experience on video assisted thoracic surgery(VATS) for thymoma and myasthenia gravis;
电视胸腔镜治疗胸腺瘤和重症肌无力
2.
Expression of single chain variable fragment A7 gene in myasthenia gravis in Pichia pastoris;
重症肌无力单链抗体A7基因在毕赤酵母中的表达
3.
Application of clinical absolute and relative score system in diagnosis for myasthenia gravis;
重症肌无力临床绝对和相对评分法在诊断中的应用
5) MG
重症肌无力
1.
Analysis of the clinical features of myasthenia gravis (MG) combined with Lambert-Eaton myasthenic syndrome (LEMS);
重症肌无力伴Lambert-Eaton肌无力综合征8例分析
2.
Comparison About the Diagnosing Value of Neostigmine Test and Repeatedly Low-frequency Stimulation in Diagnosing MG;
新斯的明试验与重复低频刺激对重症肌无力诊断意义的比较
3.
Objective: To explore the electropysiological features of patients with hyperthyroidism and myasthenia gravis (MG), and the relationship between it and chronic thyrotxic myopathy (CTM).
目的：探讨甲状腺机能亢进(甲亢)伴发重症肌无力(MG)患者的电生理检测特点,和与慢性甲状腺机能亢进性肌病(CTM)的关系。
6) myasthenia gravis (MG)
重症肌无力
1.
To observed the change of resiratory tract of 40 patients with myasthenia gravis (MG) during the therapy of thymus tissue resection or thymoma resection in this paper.
对40例重症肌无力病人切除胸腺组织或胸腺瘤治疗过程的围手术期呼吸道管理。
2.
Background and Objective Myasthenia gravis (MG) is one of autoimmune diseases caused by acetylcholine receptor antibodies (AchRAb), whose targets are the acetylcholine receptors (AchR) on the postsynaptic membrane at the neuromuscular junction (NMJ).
背景及目的 重症肌无力(myasthenia gravis，MG)主要是由乙酰胆碱受体抗体(acetylcholine receptor antibody，AchRAb)介导的，针对神经肌肉接头处突触后膜上乙酰胆碱受体(acetylcholine receptor，AchR)的自身免疫性疾病(AID)。
补充资料：肌无力
肌无力
myasthenia
肌肉衰弱收缩无力，处于过度松弛状态。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条